These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6752529)

  • 1. Effect of iron on acute pyelonephritis and later chronic changes.
    Guze LB; Guze PA; Kalmanson GM; Glassock RJ
    Kidney Int; 1982 Jun; 21(6):808-12. PubMed ID: 6752529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.
    Gupta R; Gupta S; Joshi K; Ganguly NK
    Comp Immunol Microbiol Infect Dis; 1997 Sep; 20(4):299-307. PubMed ID: 9481514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-tocopherol and cardiac toxicity of iron.
    Lindvall S; Rydén L; Smedgärd P; Swedberg B
    Scand J Haematol; 1980 Oct; 25(4):331-8. PubMed ID: 7209402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
    Prát V; Konícková L; Hatala M
    Arzneimittelforschung; 1970 Apr; 20(4):554-7. PubMed ID: 4911591
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis.
    Yagmurlu A; Boleken ME; Ertoy D; Ozsan M; Gokcora IH; Dindar H
    Urology; 2003 May; 61(5):1037-41. PubMed ID: 12736043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histological changes in the murine kidney in experimental hematogenic pyelonephritis from E. coli strains isolated from different sources].
    Bakŭrdzhiev T; Marinova R
    Eksp Med Morfol; 1981; 20(4):237-42. PubMed ID: 7035136
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis.
    Olson PD; McLellan LK; Liu A; Briden KE; Tiemann KM; Daugherty AL; Hruska KA; Hunstad DA
    Dis Model Mech; 2017 Nov; 10(11):1371-1379. PubMed ID: 28882930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriologic, histologic and functional studies of the kidney in 5 days' therapy of experimental E. coli pyelonephritis with gentamycin. Comparison with 9 days' therapy].
    Hagemann I; Briedigkeit H; Strangfeld D; Ditscherlein G; Schürer M; Pietsch R; Kruse I; Camu A; Blank W
    Z Urol Nephrol; 1985 Nov; 78(11):625-31. PubMed ID: 3913218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats].
    Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):40-3. PubMed ID: 3511839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats.
    Anğ O; Güngör M; Aricioğlu F; Inanç D; Sağduyu H; Uysal V; Küçüker M
    Int J Exp Pathol; 1990 Aug; 71(4):507-11. PubMed ID: 2400738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
    Brooks SJ; Lyons JM; Braude AI
    J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cyclophosphamide in experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Eksp Med Morfol; 1984; 23(4):186-95. PubMed ID: 6396063
    [No Abstract]   [Full Text] [Related]  

  • 13. An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    J Clin Pathol; 1980 Apr; 33(4):408-12. PubMed ID: 6995491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental pyelonephritis: the effect of chronic active pyelonephritis on renal function.
    Miller TE; Layzell D; Stewart E
    Kidney Int; 1976 Jan; 9(1):23-9. PubMed ID: 781379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Escherichia coli pyelonephritis: formation of spheroplasts in the kidney of the untreated rat.
    Demonty J
    Antonie Van Leeuwenhoek; 1970; 36(2):273-84. PubMed ID: 4914545
    [No Abstract]   [Full Text] [Related]  

  • 16. The therapeutic response of cephalosporin-treated E. coli pyelonephritis of the rat, in relation to variations of the infection model.
    Schulz E; Marre R; Herhahn D; Sack K
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):531-7. PubMed ID: 3901618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
    Sullivan MJ; Harvey RA; Shimamura T
    Yale J Biol Med; 1977; 50(3):267-73. PubMed ID: 329591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy.
    Miller T; Phillips S
    Kidney Int; 1981 May; 19(5):654-62. PubMed ID: 7026871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of methylene blue on renal scarring due to pyelonephritis in rats.
    Aksu B; Inan M; Kanter M; Oz Puyan F; Uzun H; Durmus-Altun G; Gurcan S; Aydin S; Ayvaz S; Pul M
    Pediatr Nephrol; 2007 Jul; 22(7):992-1001. PubMed ID: 17390153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model.
    Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS
    J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.